Keyes Jeffry R. 4
4 · CNS Pharmaceuticals, Inc. · Filed Jun 16, 2020
Insider Transaction Report
Form 4
Keyes Jeffry R.
Director
Transactions
- Award
Option to purchase common stock
2020-06-12+46,559→ 146,559 totalExercise: $2.47Exp: 2030-06-12→ Common Stock (46,559 underlying)
Footnotes (2)
- [F1]The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
- [F2]The stock options were issued in connection with the reporting person's Board of Director services to the Company.